CR logo
CR

Crane Co

Machinery

Crane Co (CR) Stock News

The latest CR headlines and market coverage — 30 recent stories, updated throughout the day.

  • GlobeNewswire Inc.·

    De Misano a Valencia: El equipo Geely Cyan Racing gana impulso en el FIA TCR World Tour

    Geely Cyan Racing competes in the second round of the 2026 Kumho FIA TCR World Tour at Valencia's Circuit Ricardo Tormo, building on their inaugural victory at Misano. The team showcases the new Geely Preface TCR, developed on Geely's Compact Modular Architecture (CMA), with four experienced drivers competing. The season continues the legacy of the Lynk & Co 03 TCR program's nine world titles.

  • Benzinga·

    UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND INCREASE

    Universal Health Realty Income Trust (NYSE:UHT) announced that its Board of Trustees voted to increase the quarterly dividend by $0.005, with a new dividend of $0.75 per share payable on June 30, 2026 to shareholders of record as of June 22, 2026.

  • Benzinga·

    CRACKER BARREL REPORTS THIRD QUARTER FISCAL 2026 RESULTS AND UPDATES FISCAL 2026 OUTLOOK

    Company increases revenue and adjusted EBITDA 1,2 guidance LEBANON, Tenn. , June 9, 2026 /PRNewswire/ -- Cracker Barrel Old Country Store, Inc. ("Cracker Barrel" or the "Company") (Nasdaq: CBRL) today reported its financial results for the third quarter of fiscal 2026 ended May 1, 2026. Cracker Barrel President and Chief Executive Officer Julie Masino said, "Our initiatives to improve operations, deepen guest connection, and enhance profitability continue to gain traction, with strong execution from our teams driving third quarter results that exceeded expectations. We remain focused on serving delicious food and delivering experiences guests love and believe we are well-positioned to sustain this new momentum." Third Quarter Fiscal 2026 Highlights Total revenue was $797.4 million. Compared to the prior year quarter, total revenue decreased 2.9%. Compared to the prior year quarter, comparable store restaurant sales decreased 2.6%, and comparable store retail sales decreased 1.8%. GAAP earnings per diluted share were $1.90, and adjusted 1 earnings per diluted share were $0.29. GAAP net income was $42.8 million compared to the prior year quarter GAAP net income of $12.6 million. The current year GAAP net income results include a $47.4 million benefit related to a settlement agreement regarding interchange fee litigation. Adjusted EBITDA 1 was $40.3 million compared to the prior year quarter adjusted EBITDA 1 of $48.1 million. Third Quarter Ended (In thousands, except per share amounts) 5/1/26 5/2/25 Revenue $797,367 $821,147 GAAP net income $42,811 $12,574 Adjusted net income 1 $6,533 $13,123 Adjusted EBITDA 1 $40,305 $48,117 GAAP earnings per share – diluted $1.90 $0.56 Adjusted 1 earnings per share – diluted $0.29 $0.58 Balance Sheet & Capital Allocation During the third quarter, the Company received $47.4 million, net of legal fees, pursuant to a settlement agree

  • Benzinga·

    VINFAST'S GLOBAL REVENUE IN Q1 2026 INCREASED 42% YEAR OVER YEAR

    SINGAPORE , June 8, 2026 /PRNewswire/ -- VinFast Auto Ltd. announced its unaudited financial results for the first quarter ended March 31, 2026. In the first quarter of 2026, VinFast ("the Company") delivered 58,577 electric vehicles, representing an increase of 61% from the same period last year. International markets accounted for approximately 8% of total deliveries during the quarter. In Vietnam, VinFast's EV deliveries in the first quarter of 2026 increased by 53% year over year. The Company maintained its position as the number one OEM in the domestic automotive market since September 2024. Southeast Asia and India continue to be key growth markets for VinFast. At the end of the first quarter of 2026, VinFast ranked #1 BEV brand in the Philippines, #4 in India and #8 in Indonesia. The Company also delivered 143,136 units of e-scooters and e-bikes in the first quarter, representing an increase of 219% from the first quarter of 2025. In March alone, VinFast received more than 135,000 e-scooter orders and shipped over 93,000 e-scooters to dealers in Vietnam. VinFast currently holds the leading position in Vietnam's electric motorcycle market and, in March, expanded its share of the overall motorcycle market (including both ... Full story available on Benzinga.com

  • GlobeNewswire Inc.·Neutral

    CREDIT AGRICOLE S.A. ANNONCE LE REMBOURSEMENT DE SES Obligations senior non préférées remboursables émises le 3 juin 2021 pour un montant nominal total de ¥84.200.000.000 JPY (ISIN: JP525022AM69)

    Crédit Agricole S.A. announced the redemption of ¥84.2 billion in senior non-preferred obligations issued on June 3, 2021 (ISIN: JP525022AM69). The bonds will be redeemed on July 6, 2026 at 100% of principal plus accrued interest, exercising the issuer's redemption option under the bond terms.

  • GlobeNewswire Inc.·Neutral

    CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF ¥84,200,000,000 Japanese Yen Callable Senior Non-Preferred Bonds issued on June 3, 2021 (ISIN: JP525022AM69)

    Crédit Agricole S.A. announced the redemption of ¥84.2 billion in Japanese Yen Callable Senior Non-Preferred Bonds issued on June 3, 2021. The bonds will be redeemed on July 6, 2026, at 100% of principal amount plus accrued interest. This redemption is exercised at the issuer's option under the bond conditions.

  • Benzinga·

    Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

    Roche announced it developed a Research Use Only (RUO) molecular PCR test via subsidiary TIB MOLBIOL within six days to detect the rare Ebola Bundibugyo virus. The test supports outbreak response efforts in Central and East Africa following WHO's declaration of a Public Health Emergency of International Concern on May 17, 2026. Roche is working with public health laboratories and authorities in affected regions to deploy the testing capability.

  • GlobeNewswire Inc.·

    INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Berry Global Investors Who Received Amcor plc (AMCR) Shares in Connection with Amcor’s Acquisition of Berry Global in April 2025 to Contact the Firm

    Girard Sharp LLP is investigating potential securities claims on behalf of former Berry Global investors who received Amcor plc shares in the April 2025 merger. Amcor's stock price has declined significantly since the merger closed, prompting the law firm to encourage affected investors to contact them for a free consultation.

  • The Motley Fool·

    CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential

    CRISPR Therapeutics trades at a significant discount despite Wall Street analysts rating 58% as buy with 437% upside potential. The company's first commercialized product, Casgevy, treats sickle cell disease and beta thalassemia. With only 64 patients treated in 2025 and $4.1M in sales, analysts project revenue growth to $43.9M in 2026 and $151.6M in 2027. A strong pipeline of five additional therapies in clinical trials and a large addressable market of 60,000 eligible patients position CRISPR as a potential long-term growth opportunity, though highly speculative.

  • Benzinga·

    VERSABANK REPORTS STRONG SECOND QUARTER RESULTS: STRONG US SRP GROWTH DRIVES 27% YEAR-OVER-YEAR INCREASE IN REVENUE AND NET INTEREST INCOME, 45% YEAR-OVER-YEAR GROWTH IN ADJUSTED (CORE) NET INCOME

    All amounts are unaudited and in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Our second quarter 2026 ("Q2 2026") unaudited Interim Consolidated Financial Statements for the period ended April 30, 2026 and Management's Discussion and Analysis ("MD&A"), are available online at www.versabank.com/investor-relations , SEDAR at www.sedarplus.ca and EDGAR at www.sec.gov/edgar . Supplementary Financial Information will also be available on our website at www.versabank.com/investor-relations . LONDON, ON , June 3, 2026 /CNW/ - VersaBank (or the "Bank") (TSX: VBNK (NASDAQ: VBNK ), a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today reported its results for the second quarter ended April 30, 2026. All figures are in Canadian dollars unless otherwise stated. NOTE REGARDING SECOND QUARTER FISCAL 2026 FINANCIAL RESULTS VersaBank's financial results for the second quarter of fiscal 2026 reflect non-core non-interest expenses in the amount of $6.7 million. The non-core non-interest expenses included $4.5 million related to the project costs associated with the Reorganization (see Reorganization note below). Subsequent to the end of the second quarter, the Bank publicly filed a Form S-4 registration statement (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") in connection with the Reorganization. The Reorganization is intended to enhance shareholder value, mitigate risk and reduce corporate costs over the long term. The Bank expects that the anticipated benefits of the Reorganization will exceed the associated investment however, these expected benefits are subject to various assumptions and uncertainties. As of the end of the second quarter of

  • The Motley Fool·

    CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking

    CRISPR Therapeutics acquired CTX611, a clinical-stage siRNA therapy targeting Factor XI for blood clot prevention, for $95 million upfront. The program could significantly impact the company's revenue despite being a follower in a competitive anticoagulant market dominated by Eliquis and other therapies. With only $1.4 million in Q1 2026 revenue, success with CTX611 could be transformative for the stock.

  • The Motley Fool·

    CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?

    The article compares two gene-editing biotech companies: CRISPR Therapeutics, which has FDA-approved CASGEVY therapy and stronger financials, versus Editas Medicine, which focuses on in vivo gene editing but lacks FDA approval and has a weaker balance sheet. CRISPR Therapeutics is recommended as the better 2026 investment due to its commercial-stage advantage, stronger cash position, and lower financial risk, despite Editas offering potentially greater upside if successful.

  • Benzinga·

    LOWE'S COMPANIES, INC. ANNOUNCES INCREASE IN QUARTERLY CASH DIVIDEND TO $1.25 PER SHARE

    Lowe's Companies announced a 4% increase in its quarterly cash dividend to $1.25 per share, payable August 5, 2026. The increase reflects the board's confidence in the company's strategic trajectory and disciplined capital allocation. Lowe's has maintained its Dividend Aristocrat status with over 25 consecutive years of dividend increases.

  • Benzinga·Neutral

    CRM Stock Is Down More Than 30% This Year, But Marc Benioff Says Salesforce's Blowout $11.1 Billion Quarter May Be A 'Sign'

    Salesforce reported its first $11.1 billion quarter with strong metrics including $6.7 billion operating cash flow and a 152% increase in processed tokens. However, the stock declined after the company provided Q2 revenue guidance of $11.27-$11.35 billion, slightly below analyst expectations. Despite the SaaS sector weakness, CEO Marc Benioff remains optimistic about the company's shift toward autonomous AI, though Agentforce still represents less than 5% of total sales.

  • Benzinga·

    CRM Stock Is Down More Than 30% This Year, But Marc Benioff Says Salesforce's Blowout $11.1 Billion Quarter May Be A 'Sign'

    Marc Benioff , Chair and CEO of  Salesforce   (NYSE: CRM ) , celebrated the company’s first $11.1 billion quarter by linking the company’s strong financial performance to its 1-1-1 philanthropic model. Benioff highlighted the company’s $6.7 billion operating cash flow and raised revenue guidance of $45.9-$46.2 billion. He also noted that Salesforce processed 28.6 trillion tokens, a 152% increase quarter-over-quarter, and converted them into 3.8 billion Agentic Work Units for customers, up 111% QOQ, again signaling the 1-1-1 connection. “Our first $11.1 B quarter – we have always loved the 1-1-1 model. It's a sign?” wrote the CEO. What Is the 1-1-1 Model? Salesforce's 1-1-1 model is a long-standing commitment to donate 1% of equity, product, and employee time to philanthropy, embedded at its founding in 1999 by Marc Benioff. As of recent disclosures, this framework has helped generate hundreds of millions in grants and over 10 million volunteer hours, supporting tens of thousands of nonprofits globally. The initiative has also scaled into the ... Full story available on Benzinga.com

  • Benzinga·

    Salesforce CEO Brushes Off 'SaaSpocalypse' As CRM Stock Slides Despite 60% Surge In Premium AI Deals

    Salesforce Inc. (NYSE: CRM ) shares dipped in after-hours trading on Wednesday despite a massive first-quarter earnings beat , as soft guidance and legacy weakness overshadowed an explosive under-the-hood surge in enterprise artificial intelligence (AI) adoption. Dismissing The ‘SaaSpocalypse’ While the weaker performance of the software-as-a-service (SaaS) sector has been in focus on Wall Street, Salesforce Chair and CEO Marc Benioff remained firmly defiant during the company's fiscal first-quarter earnings call. Addressing prevailing market fears head-on, Benioff pushed back against the pessimistic industry narrative. “Well, you've heard the narrative on the SaaSpocalypse,” Benioff remarked, acknowledging the “crazy thing that these AI apps are transforming software.” He instead highlighted Salesforce’s massive shift toward autonomous AI as definitive proof of structural resilience. However, not everyone on Wall Street is fully convinced by the AI pivot just yet. As Chief Analyst Patrick Moorhead at Moor Insights Strategy pointed out on X, investors remain skeptical because Agentforce still represents less than 5% of total sales, ultimately overshadowing the product’s explosive 205% ARR growth to $1.2 billion. Full story available on Benzinga.com

  • Benzinga·

    ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock

    ACRES Commercial Realty Corp. announced quarterly cash dividends on its preferred stock. The Series C Preferred Stock will pay $0.5993994 per share on July 30, 2026, while the Series D Preferred Stock will pay $0.4921875 per share on the same date. Both dividends reflect the company's commitment to returning capital to preferred shareholders.

  • Benzinga·

    Corsair's Big Bet On AI Compute Is Turning Heads After Hours: Here's What's Going On With CRSR Stock

    Shares of Corsair Gaming Inc. (NASDAQ: CRSR ) are trending on Tuesday night. CRSR shares jumped 14.09% to $9.23 in after-hours trading on Tuesday. The surge in the stock of the California-based gaming hardware maker in the late trading session follows an intraday gain of 5.06%, closing the regular session at $8.09, according to Benzinga Pro data. Company Pivots Into High-Value AI Compute Market On May 22, Corsair launched CORSAIR PRO, a new portfolio of AI workstations and servers targeting enterprise-grade compute infrastructure, marking a strategic shift beyond its core gaming-peripherals business. According to the company, the lineup includes AI workstations and server-class platforms featuring NVIDIA Grace Blackwell -based systems, with the high-performance deskside AI workstation FlexPrime V80B , powered by the NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip, among the highlighted configurations. CEO Thi La said the expansion “moves CORSAIR into professional AI ... Full story available on Benzinga.com

  • Benzinga·

    QCR Holdings, Inc. Announces Annual Meeting Results and a Cash Dividend of $0.10 Per Share

    QCR Holdings, Inc. (NASDAQ: QCRH) announced the re-election of four Class III directors at its annual meeting on May 21, 2026. The company also declared a cash dividend of $0.10 per share, payable on July 3, 2026, to shareholders of record on June 18, 2026.

  • The Motley Fool·

    Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?

    The article compares two gene-editing biotech companies: CRISPR Therapeutics, which has an approved product (Casgevy) and a deeper pipeline, versus Beam Therapeutics, a clinical-stage company with a potentially safer base-editing platform. CRISPR Therapeutics is recommended as the better investment due to its approved product, stronger cash position ($2.4B vs $1.2B), and deeper pipeline, making it less risky despite both stocks carrying clinical trial risks.

  • Benzinga·

    Top 4 S&P 500 Stocks To Watch Next Week: CRM, MRVL, COST, DELL

    The S&P 500 Index soared to a record high this week, continuing an uptrend that started in March when it crashed to $6,314. It rallied despite the elevated energy prices and bond yields, and after FOMC minutes showed that officials considered hiking interest rates. This article highlights the top stocks to watch next week, including Salesforce (NYSE: CRM ) , Marvell Technologies (NASDAQ: MRVL ), Costco Wholesale (NASDAQ: COST ) , and Dell Technologies (NASDAQ: DELL ) . Salesforce In Focus Amid SaaSpocalypse Jitters Salesforce, the biggest company in the customer relationship management industry, will be in the spotlight as it releases its earnings on Wednesday. These numbers come as its stock continues to languish after falling by 51% from its highest point in 2025 amid SaaSpocalypse fears. SaaSpocalypse is a fairly new word referring to the potential disruption of companies in the SaaS industry by AI tools. In a note this week, BofA's Tai Liam warned that the company was facing an AI-driven reset .  Analysts expect that the company's earnings will show that its revenue rose by 12% last quarter to $11 billion. Part of this growth will be because of its recent acquisitions, including Informatica and Bluebirds. Software companies have reacted differently after ... Full story available on Benzinga.com

  • GlobeNewswire Inc.·

    Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC

    Cardiff Oncology announced updated Phase 2 CRDF-004 data for onvansertib, a PLK1 inhibitor, will be presented at ASCO 2026 on June 2, 2026, with an investor webcast scheduled for June 3, 2026. The company has selected the 30 mg dose of onvansertib in combination with FOLFIRI/bevacizumab for advancement into a registrational Phase 3 trial for first-line RAS-mutated metastatic colorectal cancer, following positive dose-dependent improvements in response rates and progression-free survival.

  • Benzinga·

    METALLIUM DESCRIBES COMPANY'S METAL PROCESSING TECHNOLOGY TO COMBAT THE 'WEAPONIZATION OF THE PERIODIC TABLE' AND HALT RELIANCE ON CHINA DURING PRESENTATION AT CANACCORD GENUITY 5th ANNUAL GLOBAL METALS AND MINING CONFERENCE IN NEVADA

    Metallium Limited presented its patented Flash Joule Heating (FJH) technology at the Canaccord Genuity Global Metals and Mining Conference, positioning it as a solution to reduce U.S. reliance on China for critical metals processing. The company, which recently received a Department of War grant for gallium and germanium recovery from e-waste, is pursuing a NASDAQ uplist expected later in 2026 and focusing on urban mining/recycling and mineral processing verticals.

  • Benzinga·

    Epson's Commercial Channel Marketing Manager, Jessica Ornelas, Receives CRN 2026 Women of the Channel Recognition

    Epson announced that Jessica Ornelas, its Commercial Channel Marketing Manager, has been recognized on CRN's prestigious 2026 Women of the Channel list. Ornelas, who has spent over six years in her role, is credited with developing marketing communication tools and programs that drive partner demand and sales growth. She has contributed to strategic partner business activities, performance-based growth programs, and cross-functional collaboration initiatives.

  • The Motley Fool·Neutral

    GlobeFlex Exits NCR Atleos After Brink’s Buyout Deal

    GlobeFlex Capital sold its entire stake of 250,950 shares in NCR Atleos Corporation (valued at $10.37 million) during Q1 2026, reducing its position from 3.8% to zero AUM. The exit follows NCR Atleos' pending acquisition by Brink's, which limits future upside potential as much of the acquisition value is already reflected in the stock price.

  • GlobeNewswire Inc.·Neutral

    Univest Securities, LLC Announces Closing of $2 Million Registered Direct Offering for its Client Smart Powerr Corp. (NASDAQ: CREG)

    Univest Securities completed a $2 million registered direct offering for Smart Powerr Corp. (NASDAQ: CREG), with the company selling 4.5 million shares at $0.45 per share. Smart Powerr is a Xi'an-based energy technology company focused on waste energy recycling and energy efficiency solutions, with plans to expand into integrated energy storage solutions.

  • The Motley Fool·

    CorVel (CRVL) Q4 2026 Earnings Call Transcript

    CorVel reported Q4 2026 earnings with quarterly revenue of $249 million (7% YoY increase) and EPS of $0.61 (up 19.6%). Full-year revenue reached $959 million with EPS of $2.14 (17% increase). The company secured multiyear contracts with top national payers, achieved 56% YoY growth in new bookings, and expanded RFP activity by 20%. Network Solutions delivered double-digit growth while Patient Management showed low single-digit growth. Management emphasized investments in AI, automation, and platform integration to enhance scalability.

  • The Motley Fool·

    Lido Advisors Adds $76 Million to BSCR Stake, Making the Bond ETF Its Second-Largest Holding

    Lido Advisors increased its position in the Invesco BulletShares 2027 Corporate Bond ETF (BSCR) by $76 million in Q1 2026, making it the firm's second-largest holding at $1.4 billion (4.3% of AUM). The move reflects a defensive positioning strategy, with the short-duration bond fund offering a 4.29% yield and a defined maturity date in December 2027, appealing to institutional investors seeking income with limited interest rate risk.

  • GlobeNewswire Inc.·

    FARMERS AND MERCHANTS BANCSHARES, INC. INCREASES ITS CASH DIVIDEND BY 5.9% TO $0.36 PER SHARE

    Farmers and Merchants Bancshares, Inc. declared a cash dividend of $0.36 per share, representing a 5.9% increase from the previous dividend paid in December, with an annualized payout ratio of 33%. The dividend will be paid on June 18, 2026 to stockholders of record on June 2, 2026.

  • Benzinga·

    FARMERS AND MERCHANTS BANCSHARES, INC. INCREASES ITS CASH DIVIDEND BY 5.9% TO $0.36 PER SHARE

    Farmers and Merchants Bancshares, Inc. announced a 5.9% increase in its cash dividend to $0.36 per share on May 18, 2026. The dividend will be paid on June 18, 2026 to stockholders of record on June 2, 2026, representing an annualized payout ratio of 33%. The company, parent of Farmers and Merchants Bank chartered in Maryland in 1919, operates eight branches across Carroll and Baltimore Counties.

Showing 10 of 30 CR stories

Including: "De Misano a Valencia: El equipo Geely Cyan Racing gana impulso en el FIA TCR World Tour"

Sign up free to see all 30 + get insider-buy alerts.

Sign up free →